Verity Asset Management, Inc. Edwards Lifesciences Corp Transaction History

Verity Asset Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$82.37 - $107.29 $45,385 - $59,116	551 Added 8.33%	7,166 $592 Million
Q1 2022 May 23, 2022	BUY	$101.96 - $128.34 $674,465 - $848,969	6,615 New	6,615 $779,000
Q1 2022 May 12, 2022	SELL	$101.96 - $128.34 $644,693 - $811,493	-6,323 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$106.37 - $130.68 $112,220 - $137,867	1,055 Added 20.03%	6,323 $819,000
Q3 2021 Nov 10, 2021	BUY	$102.91 - $122.75 $32,210 - $38,420	313 Added 6.32%	5,268 $596,000
Q2 2021 Aug 04, 2021	SELL	$83.84 - $104.76 $175,309 - $219,053	-2,091 Reduced 29.68%	4,955 $513,000
Q1 2021 May 10, 2021	BUY	$78.68 - $90.67 $150,672 - $173,633	1,915 Added 37.32%	7,046 $589,000
Q4 2020 Feb 05, 2021	BUY	$71.69 - $91.23 $367,841 - $468,101	5,131 New	5,131 $468,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Verity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Verity Asset Management, Inc. with notifications on news.